Cargando…

Detection of prognostic factors in metastatic breast cancer

BACKGROUND: The aim of this study was to detect prognostic factors in recurrent breast cancer metastasis. MATERIALS AND METHODS: This retrospective cohort study employed data from 996 breast cancer patients of Isfahan Seyed-o-Shohada research center from 1998 to 2010. Stratified Cox proportional haz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tazhibi, Mehdi, Fayaz, Mahsa, Mokarian, Fariborz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793372/ https://www.ncbi.nlm.nih.gov/pubmed/24124424

Ejemplares similares

The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients
por: Rejali, Mehri, et al.
Publicado: (2015)

Comparison of satisfactions from mastectomy and Lump Ectome in breast cancer patients
por: Tazhibi, Mehdi, et al.
Publicado: (2014)

The expression of CK-19 gene in circulating tumor cells of blood samples of metastatic breast cancer women
por: Soltani, Setareh, et al.
Publicado: (2015)

Hormonal and reproductive risk factors associated with breast cancer in Isfahan patients
por: Tazhibi, Mehdi, et al.
Publicado: (2014)

Coping strategies, quality of life and pain in women with breast cancer
por: Khalili, Narjes, et al.
Publicado: (2013)

Plasma Level Of miR-21 And miR-451 In Primary And Recurrent Breast Cancer Patients
por: Motamedi, Maryam, et al.
Publicado: (2019)

Application of Multi-State Model in Analyzing of Breast Cancer Data
por: Vasheghani Farahani, Mahtab, et al.
Publicado: (2020)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Investigation on the association between breast cancer and consumption patterns of combined oral contraceptive pills in the women of Isfahan in 2011
por: Ehsanpour, Soheila, et al.
Publicado: (2013)

Belonging to a peer support group enhance the quality of life and adherence rate in patients affected by breast cancer: A non-randomized controlled clinical trial(*)
por: Tehrani, Afsaneh Malekpour, et al.
Publicado: (2011)

Trends in breast cancer incidence rates by age and tumor characteristics of women in the city of Isfahan for the period 2001-2010: An application of joinpoint analysis
por: Tazhibi, Mehdi, et al.
Publicado: (2014)

Effectiveness of trastuzumab as adjuvant therapy in patients with early stage breast cancer: A systematic review and meta-analysis
por: Davari, Majid, et al.
Publicado: (2017)

Specific TaqMan allelic discrimination assay for rs1477196 and rs9939609 single nucleotide polymorphisms of FTO gene demonstrated that there is no association between these SNPs and risk of breast cancer in Iranian women
por: Mojaver, Mahboobeh, et al.
Publicado: (2015)

Application of joinpoint regression in determining breast cancer incidence rate change points by age and tumor characteristics in women aged 30–69 (years) and in Isfahan city from 2001 to 2010
por: Dehkordi, Zahra Fazeli, et al.
Publicado: (2014)

Comparative Evaluation of Captopril, Spironolactone, and Carvedilol Effect on Endothelial Function in Breast Cancer Women Undergoing Chemotherapy
por: Hashemi Jazi, Seyed Mohammad, et al.
Publicado: (2023)

Investigation of the age trends in patients with breast cancer and different sizes of tumors in Breast Cancer Research Center of Isfahan University of Medical Sciences in 2001-2010
por: Tazhibi, Mehdi, et al.
Publicado: (2014)

The effect of combined aerobic and resistance exercises on quality of life of women surviving breast cancer
por: Taleghani, Fariba, et al.
Publicado: (2012)

A Hybrid Computer-aided-diagnosis System for Prediction of Breast Cancer Recurrence (HPBCR) Using Optimized Ensemble Learning
por: Mohebian, Mohammad R., et al.
Publicado: (2016)

Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
por: Pestechian, Nader, et al.
Publicado: (2022)

Genomic rearrangement screening of the BRCA1 from seventy Iranian high-risk breast cancer families
por: Sedghi, Maryam, et al.
Publicado: (2016)

Comparison of energy intake and requirement of young students in Isfahan, Iran
por: Tazhibi, Mehdi, et al.
Publicado: (2012)

Prognostic factors for patients with metastatic breast cancer: a literature review
por: Hu, Mengyu, et al.
Publicado: (2021)

Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis
por: Raja, Vahid, et al.
Publicado: (2022)

Prognostic factors at the time of diagnosis of metastatic breast cancer.
por: Robertson, J. F., et al.
Publicado: (1998)

Awareness Levels about Breast Cancer Risk Factors, Early Warning Signs, and Screening and Therapeutic Approaches among Iranian Adult Women: A large Population Based Study Using Latent Class Analysis
por: Tazhibi, Mahdi, et al.
Publicado: (2014)

Epidemiology and trend of cancer in Isfahan 2005-2010*
por: Mokarian, Fariborz, et al.
Publicado: (2011)

Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
por: Stravodimou, Athina, et al.
Publicado: (2013)

Retinopathy risk factors in type II diabetic patients using factor analysis and discriminant analysis
por: Tazhibi, Mahdi, et al.
Publicado: (2014)

Health information seeking behavior of female breast cancer patients
por: Ghazavi-Khorasgani, Zahra, et al.
Publicado: (2018)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases
por: Parkes, Amanda, et al.
Publicado: (2018)

Prognostic Value of the TP53 Mutation Location in Metastatic Breast Cancer as Detected by Next-Generation Sequencing
por: Bai, Han, et al.
Publicado: (2021)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer
por: Marie, Lina, et al.
Publicado: (2022)

The efficacy of hepatitis B vaccine in Iranian population: A systematic review and meta-analysis
por: Tazhibi, Mehdi, et al.
Publicado: (2014)

Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer
por: Albogami, Sarah
Publicado: (2022)

Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin
por: Bun, Ayako, et al.
Publicado: (2023)

Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer
por: Nanou, Afroditi, et al.
Publicado: (2023)

Prognostic factors in metastatic nasopharyngeal carcinoma
por: Toumi, Nabil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8q3h4bq94mv6a12to9ni1bdl6f